What is the address of CENTRE MEDICAL POLYVALENT?

The registered office of CENTRE MEDICAL POLYVALENT is located at Place de l'Eglise 15-17, 4720 Kelmis.

Is CENTRE MEDICAL POLYVALENT still active?

Yes. According to the CBE (31 October 2026) CENTRE MEDICAL POLYVALENT is active, legal situation “Normale toestand”, started on 27 June 2012.

Is CENTRE MEDICAL POLYVALENT registered on Peppol?

No, CENTRE MEDICAL POLYVALENT is currently not registered on the Peppol network.

What is the enterprise number of CENTRE MEDICAL POLYVALENT?

The enterprise number of CENTRE MEDICAL POLYVALENT is BE0846903931.

When was CENTRE MEDICAL POLYVALENT founded?

CENTRE MEDICAL POLYVALENT was founded on 27 June 2012.

Who are the directors of CENTRE MEDICAL POLYVALENT?

According to the 2025 annual accounts, the directors of CENTRE MEDICAL POLYVALENT are: Daniel SCHROEDER , Jean-Michel DECKERS.

Is CENTRE MEDICAL POLYVALENT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 June 2012; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did CENTRE MEDICAL POLYVALENT make in 2025?

CENTRE MEDICAL POLYVALENT recorded a loss after taxes of € 1,415 in financial year 2025.

What is the revenue of CENTRE MEDICAL POLYVALENT?

As a small company, CENTRE MEDICAL POLYVALENT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 112,257.

CENTRE MEDICAL POLYVALENT (Public Limited) - Kelmis

Dossier CENTRE MEDICAL POLYVALENT, printed on 31 October 2026 from databakkes.be/en/0846903931/centre-medical-polyvalent. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

CENTRE MEDICAL POLYVALENT from Kelmis, company number BE0846903931, closed financial year 2025 with a result of € -1,415 after tax. For that financial year CENTRE MEDICAL POLYVALENT recorded a gross margin of € 112,257 and equity of € 140,730. Compared with financial year 2024, the result moved from € 18,912 to € -1,415. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Healthy

€ 140,730

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1,415

▼ still € 18,912 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 145,929

▲ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -219,270.

People and assets in 2025

Wage cost

€ 998

▲ 3% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 198

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 907,617

▼ 8% vs 2024

€ 78,333 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 4,377

▲ 45% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 131,968 Gross margin 2022: € 131,968 First fiscal year in the series	€ 109,836 Gross margin 2023: € 109,836 ▼ 17% vs 2022 (€ 131,968) Unfavourable step	€ 130,545 Gross margin 2024: € 130,545 ▲ 19% vs 2023 (€ 109,836) Favourable step	€ 112,257 Gross margin 2025: € 112,257 ▼ 14% vs 2024 (€ 130,545) Unfavourable step	▼ 14%
Profit after taxes	€ 23,759 Profit after taxes 2022: € 23,759 First fiscal year in the series	€ -600 Profit after taxes 2023: € -600 ▼ € 24,359 vs 2022 (€ 23,759) Unfavourable step	€ 18,912 Profit after taxes 2024: € 18,912 ▲ € 19,512 vs 2023 (€ -600) Favourable step	€ -1,415 Profit after taxes 2025: € -1,415 ▼ € 20,327 vs 2024 (€ 18,912) Unfavourable step	▼ € 20,327
Equity	€ 123,833 Equity 2022: € 123,833 First fiscal year in the series	€ 123,234 Equity 2023: € 123,234 Unchanged (€ 123,833) Unfavourable step	€ 142,145 Equity 2024: € 142,145 ▲ 15% vs 2023 (€ 123,234) Favourable step	€ 140,730 Equity 2025: € 140,730 ▼ 1% vs 2024 (€ 142,145) Unfavourable step	▼ 1%
Total debts	€ 1,145,263 Total debts 2022: € 1,145,263 First fiscal year in the series	€ 1,087,616 Total debts 2023: € 1,087,616 ▼ 5% vs 2022 (€ 1,145,263) Favourable step	€ 1,043,558 Total debts 2024: € 1,043,558 ▼ 4% vs 2023 (€ 1,087,616) Favourable step	€ 1,005,555 Total debts 2025: € 1,005,555 ▼ 4% vs 2024 (€ 1,043,558) Favourable step	▼ 4%
Cash	€ 87,309 Cash 2022: € 87,309 First fiscal year in the series	€ 92,803 Cash 2023: € 92,803 ▲ 6% vs 2022 (€ 87,309) Favourable step	€ 124,895 Cash 2024: € 124,895 ▲ 35% vs 2023 (€ 92,803) Favourable step	€ 145,929 Cash 2025: € 145,929 ▲ 17% vs 2024 (€ 124,895) Favourable step	▲ 17%
Land & buildings	€ 1,163,893 Land & buildings 2022: € 1,163,893 First fiscal year in the series	€ 1,105,567 Land & buildings 2023: € 1,105,567 ▼ 5% vs 2022 (€ 1,163,893) Unchanged	€ 1,047,241 Land & buildings 2024: € 1,047,241 ▼ 5% vs 2023 (€ 1,105,567) Unchanged	€ 988,915 Land & buildings 2025: € 988,915 ▼ 6% vs 2024 (€ 1,047,241) Unchanged	▼ 6%
Retained profit	€ -236,167 Retained profit 2022: € -236,167 First fiscal year in the series	€ -236,766 Retained profit 2023: € -236,766 Unchanged (€ -236,167) Unfavourable step	€ -217,855 Retained profit 2024: € -217,855 ▲ € 18,912 vs 2023 (€ -236,766) Favourable step	€ -219,270 Retained profit 2025: € -219,270 ▼ € 1,415 vs 2024 (€ -217,855) Unfavourable step	▼ € 1,415
Bank debt	€ 1,121,790 Bank debt 2022: € 1,121,790 First fiscal year in the series	€ 1,062,186 Bank debt 2023: € 1,062,186 ▼ 5% vs 2022 (€ 1,121,790) Favourable step	€ 985,249 Bank debt 2024: € 985,249 ▼ 7% vs 2023 (€ 1,062,186) Favourable step	€ 907,617 Bank debt 2025: € 907,617 ▼ 8% vs 2024 (€ 985,249) Favourable step	▼ 8%
Balance sheet total	€ 1,269,097 Balance sheet total 2022: € 1,269,097 First fiscal year in the series	€ 1,210,850 Balance sheet total 2023: € 1,210,850 ▼ 5% vs 2022 (€ 1,269,097) Unchanged	€ 1,185,703 Balance sheet total 2024: € 1,185,703 ▼ 2% vs 2023 (€ 1,210,850) Unchanged	€ 1,146,286 Balance sheet total 2025: € 1,146,286 ▼ 3% vs 2024 (€ 1,185,703) Unchanged	▼ 3%

Key figures of CENTRE MEDICAL POLYVALENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CENTRE MEDICAL POLYVALENT?

What happened at CENTRE MEDICAL POLYVALENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: loss of € 1,415 (▼ € 20,327 vs 2024). Source: NBB ↗
Jun 27, 2012 New establishment in Kelmis. KBO
Jun 27, 2012 Start of the company according to the CBE. KBO
2012 Daniel SCHROEDER became a director. NBB
2012 Jean-Michel DECKERS became a director. NBB

In short

From € 23,759 profit in 2022 to € 1,415 loss in 2025.

Paid € 172 in corporate taxes since 2022.

Best year ever: 2022, with € 23,759 profit.

Original PDFs at the National Bank ↗

Management

VICTOR INVEST 27.8%

Cabinet Médical CHARLIER 16.7%

CARLIER médecine générale 16.7%

Dr. med. Erik JANSSEN 16.7%

The stake of VICTOR INVEST, Cabinet Médical CHARLIER, CARLIER médecine générale, Dr. med. Erik JANSSEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

CENTRE MEDICAL POLYVALENT

Behind CENTRE MEDICAL POLYVALENT are Daniel SCHROEDER and Jean-Michel DECKERS. The shares are held by VICTOR INVEST (27.8%), Cabinet Médical CHARLIER (16.7%), CARLIER médecine générale (16.7%) and Dr. med. Erik JANSSEN (16.7%).

Directors

According to the 2025 annual accounts

Daniel SCHROEDER

Managing director

since 2012

Jean-Michel DECKERS

Managing director

Also active at: CEJIPE-Médicale

since 2012

Shareholders

VICTOR INVEST

27.8%

Cabinet Médical CHARLIER

16.7%

CARLIER médecine générale

16.7%

Dr. med. Erik JANSSEN

16.7%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Place de l'Eglise 15-17

4720 Kelmis

2.213.868.612

Rue de la Gare 30

4728 Kelmis

Active since 27 June 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0846.903.931
VAT number: BE 0846.903.931
Registered office: Place de l'Eglise 15-17, 4720 Kelmis
Names & denominations: CENTRE MEDICAL POLYVALENT
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 27 June 2012
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

CENTRE MEDICAL POLYVALENT

Warning lights

Financials

What happened to CENTRE MEDICAL POLYVALENT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions